Studies that have evaluated associations between BMI and survival in different subtypes of breast cancer show that the most consistent evidence for the adverse impact of excess body weight is found for the commonest type of breast cancer, i.e. oestrogen receptor-positive, human epidermal growth factor receptor 2-negative (ER + ve HER2-ve) disease [5–7]. This evidence concerns the gene ERBB2 and breast carcinoma.